-
-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: stem cells
SCI and Stem Cell Clinical Trials: What’s the Latest?
In this Google Hangout, Jane Lebkowski, PhD, president of research and development at Asterias Biotherapeutics, and Kevin Whittlesey, PhD, a CIRM science officer discuss the latest progress in stem cell-based research for treatment of spinal cord injury. Asterias has a … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged CIRM, Jane Lebkowski, Kevin Whittlesey, PhD, stem cells
Comments Off on SCI and Stem Cell Clinical Trials: What’s the Latest?
Getting a grip on hand function at Dalhousie University
Professor and neurosurgeon Dr. Rob Brownstone and postdoctoral fellow Dr. Tuan Bui have identified the spinal cord circuit that controls the hands’ ability to grasp. The world’s leading neuroscience journal, Neuron, published the breakthrough finding in its latest issue. The … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Uncategorized
Tagged chronic spinal cord injury, Dalhousie Medical School, Dr. Rob Brownstone, Dr. Tuan Bui, Motor Control Lab, motor function, neural circuits, paralysis, regeneration, research, spinal cord injury research, stem cell biology, stem cells
Comments Off on Getting a grip on hand function at Dalhousie University
What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson PhD, Stephen Huhn MD, Dr. Jonathan Thomas answer questions about the StemCells Inc. human clinical trial in Zurich.
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged advocacy, Aileen Anderson PhD, axon regeneration, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, Dr. Jonathon Thomas, embryonic stem cells, motor function, neurite growth, paralysis, regeneration, spinal cord injury research, stem cell biology, stem cells, Stem Cells Inc, StemCells Inc, Stephen Huhn MD, U2FP, Unite 2 Fight Paralysis, Unite2FightParalysis, Working 2 Walk 2012
Comments Off on What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.
Neuralstem Receives FDA Approval for Chronic SCI Trial
ROCKVILLE, Md., Jan. 14, 2013 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that it received approval from the United States Food and Drug Administration (FDA) to commence a Phase I safety trial of its lead cell therapy candidate, NSI-566, … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research
Tagged chronic spinal cord injury, corticospinal tract, locomotion, motor function, Neuralstem, spinal cord injury research, stem cell biology, stem cells, U2FP, Unite 2 Fight Paralysis
Comments Off on Neuralstem Receives FDA Approval for Chronic SCI Trial
Roman Reed Foundation announces funding for paralysis research projects featured at Working 2 Walk 2012
Two presenters from Unite 2 Fight Paralysis’s 2012 Working 2 Walk Symposium held in Irvine California last month have been funded by the Roman Reed Foundation Research Grant Program. The announcement was posted on the the Roman Reed Foundation Website. … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged chronic spinal cord injury, clinical trials spinal cord injury, Dr. Hans Keirstead, Dr. Leif Havton, RIRC, Roman Reed, spinal cord injury research, stem cell biology, stem cells, U2FP, Unite 2 Fight Paralysis, Unite2FightParalysis, Working 2 Walk 2012
Comments Off on Roman Reed Foundation announces funding for paralysis research projects featured at Working 2 Walk 2012
Mark Tuszynski, MD, PhD. – Presents at Working 2 Walk 2012
These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Mark Tuszynski, MD, PhD Professor of Neurosciences, Director of the Center for Neural Repair, UC San Diego “Neural Stem Cells for … Continue reading
Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, axons, B-tublin, CAP-23, Chondroitinase ABC, chronic spinal cord injury, CIRM, clinical trials spinal cord injury, corticospinal tract, Dr. Mark Tuszynski, embryonic stem cells, ephrin, FDA, GAP-43, growth factors, MAG, myelin, netrin, NeuralStem cells (566RSC-UBQT), neurotrophic support, NIH, Nogo, paralysis, peripheral nerves, proteoglycans, PTEN, regeneration, research, semaphorin, SOCS3, spinal cord injury research, stem cell biology, stem cells, U2FP, Unite 2 Fight Paralysis, Working 2 Walk 2012
Comments Off on Mark Tuszynski, MD, PhD. – Presents at Working 2 Walk 2012
Translation of Stem Cell Based Therapies
Hans Keirstead, PhD Professor of Anatomy & Neurobiology, Neurological Surgery, University of California at Irvine Reeve-Irvine Research Center Additional Information:
Posted in Advocacy, Chronic Spinal Cord Injury Research, Gene Therapy, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, California Stem Cells, chronic spinal cord injury, Dr. Hans Keirstead, embryonic stem cells, FDA, locomotion, motor function, neurite growth, NIH, paralysis, RIRC, stem cells
Comments Off on Translation of Stem Cell Based Therapies
Dr. Keith Tansey: Shepherds Center – SCI-Animal Studies- Stem Cells-Clinical Trials-Translation-Stem Cell Clinical Trials
SCI-Animal Studies- Stem Cells-Clinical Trials-Translation-Stem Cell Clinical Trials Dr. Keith Tansey from Shepherds Center Additional Information:
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged academic researchers, advocacy, axon regeneration, chronic spinal cord injury, clinical trials, clinical trials spinal cord injury, Dr. Keith Tansey, locomotion, motor function, Shepherd Center, stem cell biology, stem cells
Comments Off on Dr. Keith Tansey: Shepherds Center – SCI-Animal Studies- Stem Cells-Clinical Trials-Translation-Stem Cell Clinical Trials
Cell-Based Therapies for SCI: Lessons Learned in Planning and Conducting Two Phase 1 Safety Trials Over the Past 18 Years
Ed Wirth, MD, PhD Spinal Cord Injury Clinical Scientist
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged chronic spinal cord injury, clinical trials, clinical trials spinal cord injury, Dr. Ed Wirth, embryonic stem cells, paralysis, regeneration, RIRC, Roman Reed, stem cell biology, stem cells
Comments Off on Cell-Based Therapies for SCI: Lessons Learned in Planning and Conducting Two Phase 1 Safety Trials Over the Past 18 Years
SPINAL CORD INJURY RESEARCH AND SCIENCE 